It has been reported that PTS (2) is a more potent melanogenesis inhibitor than RES (1) in α-melanocyte-stimulating hormone-stimulated B16F10 melanoma cells, and PTS (2) inhibited tyrosinase activity in a dose-dependent manner [75]. Here, TYR is linked to melanoma.